> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection on Expedited Drug Programs
- URL: https://www.fdaweb.com/info-collection-on-expedited-drug-programs/
- Published: 2020-11-18T12:00:00.000Z
- Updated: 2026-09-14T16:36:57.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148111

*Federal Register* notice: FDA is seeking comments on an information collection extension entitled “Expedited Programs for Serious Conditions — Drugs and Biologics” (OMB Control Number 0910-0765). The collection supports agency procedures designed to expedite the development, evaluation, and marketing of new therapies intended to treat persons with life-threatening and severely debilitating illnesses, especially where no satisfactory alternative therapy exists. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-11-18/pdf/2020-25414.pdf?ref=fdaweb.com).